Research solution identifying optimal timing for SAR activator application to prevent fire blight canker development in apple and pear trees. Uses pathogenesis-related gene expression profiling in bark to demonstrate systemic acquired resistance as a defense mechanism against Erwinia amylovora.
This research addresses fire blight, a devastating bacterial disease caused by Erwinia amylovora that affects apple and pear orchards worldwide. The solution focuses on understanding systemic acquired resistance (SAR) activation in tree bark during canker formation, enabling growers to apply SAR-activating compounds at the optimal time to prevent canker development on perennial wood.
Fire blight cankers serve as the primary overwintering source of the pathogen, producing bacteria in spring that initiate new infections. By identifying when SAR defense mechanisms activate in bark tissue, this research provides a scientific basis for targeted chemical applications that could significantly reduce disease pressure and the need for antibiotic sprays.
Research approach:
Key findings to date:
This research is at an early validation stage (TRL 3-4). One year of data collection has been completed, showing promising PR gene expression patterns in both resistant and susceptible cultivars. A second year of validation is needed to confirm consistency of results across seasons and cultivars. The research team is seeking funding for a Postdoctoral Associate to complete RNA extractions, qRT-PCR assays, and comparative analysis. Upon completion, findings will provide proof-of-concept for SAR activator timing recommendations in commercial orchard management, with potential for development into grower-applicable decision tools for fire blight management.
Virginia Polytechnic Institute and State University (Virginia Tech) is a comprehensive public land‑grant research university with broad graduate and professional programs and a strong industry orientation. An adjacent research and technology park links companies with faculty, shared labs, and prototyping resources, while facilities in the National Capital Region create a direct connection to federal partners and supply‑chain collaborators. Integration with a regional health system supports clinical research and translational pathways, and the statewide extension network enables field deployment and validation with industry and communities. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and the Department of Defense. A dedicated technology transfer office provides IP management, licensing, startup formation, and industry contracting support.